Učitavanje...
Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control
BACKGROUND: The management of asthma has changed since the introduction of budesonide/formoterol (Symbicort(®)) as both maintenance and reliever therapy (SMART). SMART and its effects on bronchial hyperresponsiveness (BHR) have not been studied in primary care. AIMS: To compare the effects of SMART...
Spremljeno u:
| Izdano u: | Prim Care Respir J |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6548307/ https://ncbi.nlm.nih.gov/pubmed/22015542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4104/pcrj.2011.00090 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|